Anthony Fischer

Dr. Anthony Fischer


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2014 in Science
Verified
Journal Article
Closed access
PDF file
MHMark J. Hoegger
Mark J. Hoegger
AFAnthony Fischer
Anthony Fischer
JMJames D. McMenimen
James D. McMenimen
LOLynda S. Ostedgaard
Lynda S. Ostedgaard
ATAlex J. Tucker
Alex J. Tucker
MWMichael J. Welsh
Michael J. Welsh
A breathtaking tale of sticky mucus: Patients with cystic fibrosis have difficulty breathing because their airways are clogged with thick mucus. Does this mucus accumulate because there is a defect in the way it is produced? Or does it accumulate because of other disease features, such as dehydration or airway wall remodeling? Distinguishing between these possibilities is important for future drug development. In a study of piglets with cystic fibrosis, Hoegger et al. identify mucus production as the primary defect (see the Perspective by Wine). The airway glands of the piglets synthesized strands of mucus normally, but the strands were never released and stayed tethered to the gland ducts. Science , this issue p. 818 ; see also p. 730

1 February 2006 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
SHStephen G. Hummel
Stephen G. Hummel
AFAnthony Fischer
Anthony Fischer
SMSean M. Martin
Sean M. Martin
FSFreya Q. Schafer
Freya Q. Schafer
GBGarry Buettner
Garry Buettner

1 January 2008
Verified
Book Chapter
Closed access
JBJennifer A. Bartlett
Jennifer A. Bartlett
AFAnthony Fischer
Anthony Fischer
PMPaul Mccray
Paul Mccray
The epithelium of the respiratory tract forms a large surface area that maintains intimate contact with the environment. Through the act of breathing, this mucosal surface encounters an array of pathogens and toxic particulates. In response to these challenges many strategies have evolved to protect the host. These include the barrier functions of the epithelium, cough, mucociliary clearance, resident professional phagocytes, and the secretion of a number of proteins and peptides with host defense functions. Thus, the surface and submucosal gland epithelium of the conducting airways is a constitutive primary participant in innate immunity. In addition, this tissue may serve the function of a secondary amplifier of innate immune responses following neurohumoral input, stimulation with cytokines from cells such as alveolar macrophages, or engagement of pattern recognition receptors. Here, we provide an overview of the airway epithelium's role in pulmonary innate immunity, especially in the context of bacterial and viral infections, emphasizing findings from human cells and selected animal models. We also provide examples of human disease states caused by impaired epithelial defenses in the lung.

1 February 2021 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
AFAnthony Fischer
Anthony Fischer
SSSachinkumar B. Singh
Sachinkumar B. Singh
MLMason M. LaMarche
Mason M. LaMarche
LMLucas J. Maakestad
Lucas J. Maakestad
ZKZoe E. Kienenberger
Zoe E. Kienenberger
DLDominique H. Limoli
Dominique H. Limoli
Rationale: Staphylococcus aureus and Pseudomonas aeruginosa often infect the airways in cystic fibrosis (CF). Because registry studies show higher prevalence of P. aeruginosa versus S. aureus in older patients with CF, a common assumption is that P. aeruginosa replaces S. aureus over time. In vitro, P. aeruginosa can outgrow and kill S. aureus. However, it is unknown how rapidly P. aeruginosa replaces S. aureus in patients with CF. Methods: We studied a longitudinal cohort of children and adults with CF who had quantitative sputum cultures. We determined the abundance of P. aeruginosa and S. aureus in cfu/ml. We determined the duration and persistence of infections and measured longitudinal changes in culture positivity and abundance for each organism. Measurements and Main Results: Between 2004 and 2017, 134 patients had ≥10 quantitative cultures, with median observation time of 10.15 years. One hundred twenty-four patients had at least one positive culture for P. aeruginosa, and 123 had at least one positive culture for S. aureus. Both species had median abundance of >106 cfu/ml. Culture abundance was stable over time for both organisms. There was an increase in the prevalence of S. aureus/P. aeruginosa coinfection but no decrease in S. aureus prevalence within individuals over time. Conclusions: S. aureus and P. aeruginosa are abundant in CF sputum cultures. Contrary to common assumption, we found no pattern of replacement of S. aureus by P. aeruginosa. Many patients with CF have durable long-term coinfection with these organisms. New strategies are needed to prevent and treat these infections.

1 October 2011 in American Journal of Respiratory Cell and Molecular Biology
Verified
Journal Article
Closed access
AFAnthony Fischer
Anthony Fischer
NLNicholas J. Lennemann
Nicholas J. Lennemann
SKSateesh Krishnamurthy
Sateesh Krishnamurthy
PPPéter Pócza
Péter Pócza
LDLakshmi Durairaj
Lakshmi Durairaj
PMPaul Mccray
Paul Mccray
Recent reports postulate that the dual oxidase (DUOX) proteins function as part of a multicomponent oxidative pathway used by the respiratory mucosa to kill bacteria. The other components include epithelial ion transporters, which mediate the secretion of the oxidizable anion thiocyanate (SCN−) into airway surface liquid, and lactoperoxidase (LPO), which catalyzes the H2O2-dependent oxidation of the pseudohalide SCN− to yield the antimicrobial molecule hypothiocyanite (OSCN−). We hypothesized that this oxidative host defense system is also active against respiratory viruses. We evaluated the activity of oxidized LPO substrates against encapsidated and enveloped viruses. When tested for antiviral properties, the LPO-dependent production of OSCN− did not inactivate adenovirus or respiratory syncytial virus (RSV). However, substituting SCN− with the alternative LPO substrate iodide (I−) resulted in a marked reduction of both adenovirus transduction and RSV titer. Importantly, well-differentiated primary airway epithelia generated sufficient H2O2 to inactivate adenovirus or RSV when LPO and I− were supplied. The administration of a single dose of 130 mg of oral potassium iodide to human subjects increased serum I− concentrations, and resulted in the accumulation of I− in upper airway secretions. These results suggest that the LPO/I−/H2O2 system can contribute to airway antiviral defenses. Furthermore, the delivery of I− to the airway mucosa may augment innate antiviral immunity.

28 January 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MHMark J. Hoegger
Mark J. Hoegger
MAMaged Awadalla
Maged Awadalla
ENEman Namati
Eman Namati
OIOmar A. Itani
Omar A. Itani
AFAnthony Fischer
Anthony Fischer
MWMichael J. Welsh
Michael J. Welsh
Significance: Mucociliary transport (MCT) defends lungs by removing particulates, and defective MCT is hypothesized to contribute to the onset of lung diseases such as asthma, chronic bronchitis, and cystic fibrosis. However, testing those hypotheses has been limited by current MCT assays and mouse models of human disease. We developed an in vivo MCT assay in newborn pigs, which share physiological and anatomical features with humans. The X-ray–computed tomographic-based method provided high spatial and temporal resolution. We discovered that particles preferentially travel up the ventral airway surface. We also discovered substantial heterogeneity in rates of individual particle movement, indicating that MCT does not likely involve homogeneous mucus blankets. The granularity of the data may aid understanding of MCT and disease pathogenesis.